RadNet Inc header image

RadNet Inc

RDNT

Equity

ISIN US7504911022 / Valor 2812237

NASDAQ (2024-09-18)
USD 67.11+0.45%

RadNet Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

RadNet Inc. is a leading provider of outpatient diagnostic imaging services in the United States, operating over 365 freestanding, fixed-site centers. The company offers a comprehensive range of imaging services, including MRI, CT, PET/CT, mammography, ultrasound, and X-ray. RadNet's IT division, eRAD, specializes in delivering integrated, web-based, cloud solutions designed to streamline medical imaging workflows. Additionally, RadNet Television (RTV) provides targeted programming for patients and their families, enhancing the overall patient experience. The company's extensive network and advanced technological solutions position it as a significant player in the medical imaging industry.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (13.06.2024):

Revenue Growth

In the first quarter of 2024, RadNet Inc. reported a significant increase in total company revenue, which rose by 10.5% to $431.7 million from $390.6 million in the first quarter of 2023. This growth was notably driven by the performance of the Digital Health segment, where revenue surged by 32.3% to $14.7 million.

EBITDA Improvement

RadNet Inc. experienced a robust increase in its Adjusted EBITDA(1) for the first quarter of 2024, reaching $58.5 million, up 21.4% from $48.2 million in the same quarter of the previous year. This improvement reflects enhanced operational efficiency and effective cost management across the company.

AI Revenue Surge

The Digital Health segment of RadNet Inc. saw a remarkable increase in AI Revenue, which climbed by 118.8% to $4.7 million in the first quarter of 2024, up from $2.1 million in the first quarter of 2023. This growth highlights the successful expansion and adoption of AI technologies within the company's offerings.

Net Loss Reduction

Despite the revenue and EBITDA gains, RadNet Inc. reported a net loss of $2.8 million in the first quarter of 2024, which, however, was a significant improvement from a net loss of $21.0 million in the first quarter of 2023. The reduction in net loss is indicative of the company's ongoing efforts to streamline operations and reduce costs.

Guidance Revision

Following the strong performance in the first quarter of 2024, RadNet Inc. has revised its full-year guidance upwards, reflecting increased optimism about its revenue, Adjusted EBITDA(1), and Free Cash Flow(2) projections for the year. This revision suggests confidence in the company's continued growth trajectory and operational success.

Summarized from source with an LLMView Source

Key figures

140%1Y
135%3Y
346%5Y

Performance

39.1%1Y
43.9%3Y
56.2%5Y

Volatility

Market cap

4941 M

Market cap (USD)

Daily traded volume (Shares)

436,042

Daily traded volume (Shares)

1 day high/low

68.91 / 65.44

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Stryker Corp
Stryker Corp Stryker Corp Valor: 974330
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.71%USD 361.36
Boston Scientific Corp
Boston Scientific Corp Boston Scientific Corp Valor: 913577
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.06%USD 82.57
Estee Lauder Companies Inc
Estee Lauder Companies Inc Estee Lauder Companies Inc Valor: 99350
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.11%USD 88.00
Edwards Lifesciences Corp
Edwards Lifesciences Corp Edwards Lifesciences Corp Valor: 1065343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.45%USD 67.53
Draegerwerk AG & Co. KGaA
Draegerwerk AG & Co. KGaA Draegerwerk AG & Co. KGaA Valor: 330446
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.89%EUR 45.30
Resmed Inc
Resmed Inc Resmed Inc Valor: 321632
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.12%USD 238.03
MEDICLIN AG
MEDICLIN AG MEDICLIN AG Valor: 1158721
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.71%EUR 2.38
Vita 34 AG
Vita 34 AG Vita 34 AG Valor: 2333201
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.93%EUR 4.40
Teleflex Inc
Teleflex Inc Teleflex Inc Valor: 976212
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.04%USD 241.53
Shield Therapeutics PLC
Shield Therapeutics PLC Shield Therapeutics PLC Valor: 29778101
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.71%GBP 0.042